Local Storage seems to be disabled in your browser.
For the best experience on our site, be sure to turn on Local Storage in your browser.

Sucralfaat FNA 500ml Suspension

Nr.
28026
Brand:
Grovet
Batch:
20I30
Expiry date:
30-Sep-2021
For the treatment of ulcers in the stomach or duodenum.
More info

Sucralfate 125 g suspension in Sirupus Simplex 500 ml

Sweet-tasting suspension of Sucralfate. 

Indication
For the treatment of ulcers in the duodenum and pars glandularis of the stomach.

Dosage
Recommended dosage 12-20 mg/kg b.w. sucralfate PO BID - TID  24-40 ml sucralfate suspension/ 500 kg b.w.. horse PO BID - TID 

Method of action
Sucralfate is a sucrose sulphate-aluminium complex with a triple mode of action:

  1. Directly inhibits the action of pepsin and bile
  2. Creates a protective barrier on the surface of the ulcer by binding with proteins exuded from the ulcer itself.
  3. Prevents pepsin, gastric acid and bile from diffusing across this barrier.

Combination with other medication
Sucralfate can be used in combination with antacids, H2 receptor antagonists and proton pump inhibitors. There is no interaction between these drugs and sucralfate. It is however advisable to wait a few hours between the administration of Sucralfate and other medication.

Sucralfate is largely (>95%) unabsorbed and stays in the gastrointestinal tract. The few percent that are absorbed have a short half-life.

 

Sucralfate is permitted by the FEI.

More Information
Nr.28026
Registration numberCompounding
BrandGrovet
Chilled itemNo
Active IngredientSucralfate
Legal status of supplyPOM
Batch20I30
Expiry dateSep 30, 2021
Units per outer box0
Ingredients Sucralfate
© 2020 Grovet B.V. All rights reserved.